Baylor University researchers have developed a novel approach to fight colorectal cancer, using modified bacteria as a courier to deliver potent cancer-killing proteins into tumor cells.
From cobblers to smoothies, dark sweet cherries show up in plenty of recipes, and scientists say the crimson-colored fruit may contain compounds that could help fight an aggressive type of breast cancer.
A team from the University of Barcelona has designed and validated in animal models an innovative compound with a pioneering mechanism of action for the treatment of Alzheimer’s disease.
Researchers at Mass General Brigham have developed a series of artificial intelligence (AI) tools that uses machine learning to identify individuals who may be at risk for intimate partner violence (IPV) using information from their electronic medical records (EMRs).
Characterized by weakened or damaged heart musculature, heart failure results in the gradual buildup of fluid in a patient’s lungs, legs, feet, and other parts of the body. The condition is chronic and incurable, often leading to arrhythmias or sudden cardiac arrest. For many centuries, bloodletting and leeches were the treatment of choice, famously practiced by barber surgeons in Europe, during a time when physicians rarely operated on patients.
ANDOVER, Mass. and HAIFA, Israel, March 11, 2026 /PRNewswire/ — MeMed, a leader in advanced host-response diagnostics, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to MeMed BV Flex™, a test designed to accurately distinguish between bacterial and viral infections based on the body’s immune response.
WESTBOROUGH, Mass., March 11, 2026 /PRNewswire/ — Olympus Corporation proudly announces the U.S. launch of the VISERA ELITE™ III surgical imaging platform designed to enhance surgical visualization, workflow efficiency, and multispecialty flexibility. The VISERA ELITE III platform is a significant leap forward in surgical imaging and the third major co-developed product by SONY Olympus Medical (SOMED), a joint venture established in 2013.
New product line extends options to better meet patient needs
LifeVac is approved for use as a single-use, non-powered, non-invasive airway clearance device.
A new technology has been developed to suppress immune rejection, the biggest challenge in organ transplantation, without causing systemic side effects.